PMID: 8473422

Patrizio P, Asch RH, Handelin B, Silber SJ
Aetiology of congenital absence of vas deferens: genetic study of three generations.
Hum Reprod. 1993 Feb;8(2):215-20., [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:5:88
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:5:110
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:5:104
status: NEW
view ABCC7 p.Arg553* details
Four patients were found to be compound heterozygotes, three with genotypes Delta F-508/R117H, one with R553X/R117H. Login to comment
45 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:45:44
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:45:193
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 8473422:45:410
status: NEW
view ABCC7 p.Gly542* details
In six patients the mutation identified was W1282X, a nonsense mutation, localized on exon 20 and predicting the production of truncated polypeptides of CFTR; one patient was found to have the R553X mutation, a nonsense mutation of the CG to TG rule localized on exon 11; one patient had the mutation 1717G-A, localized on intron 10, which would cause defective RNA splicing; one patient was found to have the G542X mutation, a nonsense mutation in exon 11. Login to comment
46 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:46:97
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:46:122
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:46:116
status: NEW
view ABCC7 p.Arg553* details
Four of the 26 patients were found to be compound heterozygotes, three with genotypes Delta F508/R117H and one with R553X/R117H. Login to comment
47 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:47:13
status: NEW
view ABCC7 p.Arg117His details
The mutation R117H was a missense mutation localized on exon 4. Login to comment
51 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 8473422:51:164
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:51:229
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:51:178
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:51:171
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 8473422:51:157
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 8473422:51:222
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 8473422:51:215
status: NEW
view ABCC7 p.Arg560Thr details
Exon 4,10,11,20 and 21 were amplified in a multiplex reaction followed by allele specific oligonucleotide (ASO) probe analysis for the mutations Delta F508, G542X, G551D, R553X, W1282X, N13O3K, Delta 1507, 1717G-A, R560T, S549N, R117H and 621 + 1. Login to comment
85 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:85:137
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:85:149
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:85:161
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:85:173
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:85:274
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:85:365
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:85:480
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:85:91
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:85:99
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:85:107
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:85:115
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:85:123
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:85:349
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:85:167
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:85:179
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 8473422:85:195
status: NEW
view ABCC7 p.Gly542* details
DF5O8/ DF5O8/ DF5O8/ DF508/ DF508/ DF508/ DF508/ DF5O8/ DF5O8/ DF5O8/ DF508/ DF5O8/ DF508/ W1282X/ W1282X/ W1282X/ W1282X/ W1282X/ DF508/R117H DF508/R117H DF508/R117H R553X/R117H R553X/ 1717G-A/ G542X/ Neg. NA NA NA NA DF508 NA NA NA Neg. NA NA NA NA Neg. NA NA NA DF508 NA R117H NA NA 1717G-A NA DF508 Neg. NA NA NA Neg. NA NA NA DF508 NA NA NA NA W1282X NA NA NA R117H NA DF508 NA NA Neg. NA Neg. Neg. NA NA NA Neg. NA Neg. Neg. Neg. Neg. Neg. Neg. NA Neg. NA Neg. Neg. Neg. NA R117H NA NA NA Neg. (g) DF508 - ... - - (g) Neg. - ... _. - - - - (b) Neg. - ... - - (g) DF5O8 (b) DF508 - - - (b) Neg. - b = boy; g = girl; NA = data not available; -, no offspring; DF5O8 = Delta F508. Login to comment
86 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:86:95
status: NEW
view ABCC7 p.Trp1282* details
of the less common CF mutations were seen in significantly greater frequency in CAVD patients: W1282X had a frequency of 12% compared to <2% among CF patients, and Rl 17H had a frequency of 8% compared to < 1% in CF patients. Login to comment
89 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:89:138
status: NEW
view ABCC7 p.Trp1282* details
Table I shows that of the eight mothers tested in the CAVD-CF+ group of patients, five were found to be carriers (one for Rl 17H, one for W1282X, and three for Delta F508). Login to comment
92 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:92:201
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:92:320
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:92:207
status: NEW
view ABCC7 p.Trp1282* details
Cystic fibrosis (CF) mutation frequency in patients with CF and isolated bilateral congenital absence of vas deferens (CAVD) CF mutation Frequency in CF patients Frequency in CAVD CF positive patients R117H W1282X DF508 0.3% (3/812)a 1.6% (9/578) 73% (593/812) 8% (4/52) 12% (6/52) 31% (16/52) a (3/812) indicates three R117H alleles among 812 CF alleles (in 406 patients). Login to comment
95 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:95:6
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:95:0
status: NEW
view ABCC7 p.Arg553* details
R553X/R117H NA NA 2. Login to comment
96 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:96:19
status: NEW
view ABCC7 p.Arg117His details
DF508/R117H3 DF508 R117H 3. Login to comment
97 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:97:6
status: NEW
view ABCC7 p.Arg117His details
DF508/R117H NA NA 4. Login to comment
98 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:98:13
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:98:78
status: NEW
view ABCC7 p.Arg117His details
DF508/R117Ha R117H DF508 NA Neg. (g) DF508 Normal NA (b) DF508 Normal (+ vas) R117H - ??? Login to comment
113 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:113:85
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:113:151
status: NEW
view ABCC7 p.Arg117His details
Of the 28 wives tested, only one (3.6%) was found to be a carrier for a CF mutation (R117H), while her husband was a compound heterozygote (Delta F508/R117H). Login to comment
123 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:123:116
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:123:122
status: NEW
view ABCC7 p.Arg553* details
Of these, four patients were found to be compound heterozygotes, three with genotype Rl 17H/Delta F5O8 and one with R117H/R553X. Login to comment
127 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:127:201
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 8473422:127:208
status: NEW
view ABCC7 p.Gly542* details
However in the present study, we extended the genetic screening to the parents and the offspring of men with CAVD and moreover, by testing for 12 CF mutations, we demonstrated other rare CF mutations (R117H, G542X and 1717G-A) in patients with CAVD. Login to comment
129 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:129:180
status: NEW
view ABCC7 p.Arg117His details
However, by analysing the results of genetic testing of fathers of patients with CAVD, we found four carriers for known CFTR mutations of which two carried Delta F508, one carried R117H and one 1717G-A. Login to comment
137 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:137:223
status: NEW
view ABCC7 p.Arg553* details
In the four patients identified as compound heterozygotes for two CF mutations and whose only CF-related symptom is absence of the vas deferens, all have one Rl 17H mutation in combination with either Delta F508 (n = 3) or R553X mutations (n = 1). Login to comment
138 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:138:76
status: NEW
view ABCC7 p.Arg117His details
Sweat chloride tests were only performed on two of the genotypes Delta F508/R117H and both were normal (40 and 45 mmol/1). Login to comment
139 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:139:66
status: NEW
view ABCC7 p.Arg117His details
This is the first time that compound heterozygotes for Delta F508/R117H have been found to have normal sweat chloride tests and CAVD as the only phenotypical expression of CF disease. Login to comment
140 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:140:89
status: NEW
view ABCC7 p.Arg117His details
218 This finding is consistent with another report of mild CF cases involving Delta F508/R117H genotypes (Dean et al. Login to comment
141 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:141:32
status: NEW
view ABCC7 p.Arg117His details
1990) where it appears that the R117H mutation opposite Delta F508 may moderate the more severe phenotype of the homozygous Delta F508 genotype. Login to comment
144 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:144:197
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:144:131
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:144:187
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 8473422:144:151
status: NEW
view ABCC7 p.Gly542* details
The six CFTR mutations identified in this study occur on four exons plus one intron and represent deletion (Delta F508), nonsense (W1282X, 1717G-A and G542X) and amino acid substitution (R553X and R117H) mutations. Login to comment
145 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8473422:145:0
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:145:63
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8473422:145:74
status: NEW
view ABCC7 p.Arg553* details
R117H is one of the transmembrane regions of CFTR, Delta F508, W1282X and R553X are in nucleotide binding regions, and 1717G-A is at the splice border of intron 10 (Kerem et al., 1990; Cutting et al., 1990; Dean et al, 1990). Login to comment
147 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:147:32
status: NEW
view ABCC7 p.Trp1282* details
Indeed, 1717G-A, Delta F508 and W1282X are associated with the pancreatic insufficient CF phenotype (Kerem et al., 1990) which tends to be a more severe phenotype, whereas Rl 17H has been found only in mildly affected individuals (Dean et al, 1990). Login to comment
148 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:148:34
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8473422:148:126
status: NEW
view ABCC7 p.Trp1282* details
Four of the six patients with the W1282X mutation were Jewish Ashkenazi and this is in agreement with a previous report where W1282X was found to be the most common CF mutation in this ethnic group (Shashani et al., 1992). Login to comment